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Abstract
Background: Decreased airway lumen size and increased lung volume are major structural changes in chronic
obstructive pulmonary disease (COPD). However, even though the outer wall of the airways is connected with lung
parenchyma and the mechanical properties of the parenchyma affect the behaviour of the airways, little is known
about the interactions between airway and lung sizes on lung function and symptoms. The present study
examined these effects by establishing a novel computed tomography (CT) index, namely, airway volume percent
(AWV%), which was defined as a percentage ratio of the airway tree to lung volume.
Methods: Inspiratory chest CT, pulmonary function, and COPD Assessment Tests (CAT) were analysed in 147 stable
males with COPD. The whole airway tree was automatically segmented, and the percentage ratio of the airway tree
volume in the right upper and middle-lower lobes to right lung volume was calculated as the AWV% for right lung.
Low attenuation volume % (LAV%), total airway count (TAC), luminal area (Ai), and wall area percent (WA%) were
also measured.
Results: AWV% decreased as the Global Initiative for Chronic Obstructive Lung Disease (GOLD) spirometric grade
increased (p < 0.0001). AWV% was lower in symptomatic (CAT score ≥ 10) subjects than in non-symptomatic
subjects (p = 0.036). AWV% was more closely correlated with forced expiratory volume in 1 s (FEV1) and ratio of
residual volume to total lung capacity (RV/TLC) than Ai, Ai to lung volume ratio, and volume of either the lung or
the airway tree. Multivariate analyses showed that lower AWV% was associated with lower FEV1 and higher RV/TLC,
independent of LAV%, WA%, and TAC.
Conclusions: A disproportionally small airway tree with a relatively large lung could lead to airflow obstruction and
gas trapping in COPD. AWV% is an easily measured CT biomarker that may elucidate the clinical impacts of the
airway-lung interaction in COPD.
Keywords: Chronic obstructive pulmonary disease, Computed tomography, Airway, Pulmonary function,
Emphysema, Symptom
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Background
Chronic obstructive pulmonary disease (COPD) is
characterized by expiratory airflow obstruction that is
caused by a combination of emphysematous destruc-
tion of the parenchyma and disease of the small
airways [1]. Because obtaining pathological samples of
lung tissue is too invasive to perform in clinical
practice, chest computed tomography (CT) has been
used to obtain separate estimations of these two
pathological lesions [2]. Emphysematous changes mea-
sured by CT is associated with worsening of lung
function [3] and symptoms [4], frequent exacerbation
[5], and poor prognosis [6]. In addition, loss of elastic
recoil due to emphysema causes lung hyper-expansion
that can also be quantified as total lung volume in
CT [7]. The CT-measured total lung volume has been
used for evaluating the effects of pharmacological,
bronchoscopic, and surgical lung volume reduction, as
well as lung growth [8–11].
Although small airways cannot be visualized by CT
due to the resolution limitation [3, 12], measurements of
the central airway dimensions are informative because
these dimensions reflect the histological features of small
airway disease [13]. In particular, a small airway lumen
area in COPD is an important CT finding that is closely
correlated with airflow obstruction, as assessed by forced
expiratory volume in 1 s (FEV1) [14, 15] and gas trap-
ping, as assessed by residual volume (RV), or its ratio to
total lung capacity (TLC) [RV/TLC] [7]. Moreover, these
smaller lumens of the airways reduce the number of
airways visible on CT, and this impaired visibility is
currently assessed as total airway count (TAC) [16],
which has been shown to be associated with FEV1, dys-
pnoea, exercise tolerance and future lung function
decline [16, 17].
Since the outer wall of the airways is connected with
the lung parenchyma, the mechanical properties of the
parenchyma affect the behaviour of the airways [18].
This airway-parenchyma interdependence allows the
elastic recoil of the lung to maintain airway calibre, indi-
cating that any disease condition inducing loss of elastic
recoil could reduce airway calibre [19]. Indeed, histo-
logical and microCT analyses have shown that loss of
the alveolar attachments to the outer wall of the small
airways is closely correlated with lumen narrowing in
emphysema [20–22]. A CT study by Diaz et al. [23] also
showed that segmental and subsegmental airways are
distended during breathing up to the TLC level in
healthy lungs, but this distensibility is diminished in
hyper-inflated emphysematous lung and further reduc-
tion of the lumen area occurs at full inspiration. More-
over, physiological and CT imaging studies have shown
that the association between airway and lung sizes is not
constant even in healthy subjects [24, 25], and suggested
that dysanaptic lung growth that is characterized by an
increase in lung size without change in airway size in
early life might impair lung function [9, 25], supporting
a recent notion that abnormal lung growth potentially
affects COPD development [26]. However, little is still
known about the interaction between airway and lung
sizes on lung function and symptoms in COPD.
It was hypothesized that a reduction in the ratio of
airway tree volume to lung volume could be a major
determinant of impaired pulmonary function and clin-
ical symptoms in COPD. To test this hypothesis, the
present study aimed to establish a novel CT marker,
namely, airway volume percent (AWV%), that was
defined as a percentage ratio of the airway tree vol-
ume to the entire lung volume and to explore the
associations of the AWV% with lung function and




This study was performed in accordance with the Dec-
laration of Helsinki. This human study was approved by
the Ethics Committee of Kyoto University (approval No.
E182). Written informed consent was obtained from all
participants.
Study subjects
The data used in the present analysis were based on those
from a prospective observational study performed at
Kyoto University [27, 28]. The inclusion criteria were (1) a
smoking history of at least 20 pack-years, (2) COPD diag-
nosis, and (3) no history of lung resection surgery or other
lung diseases, such as bronchial asthma or interstitial lung
disease. All male patients who underwent chest inspira-
tory CT scans and completed lung function testing includ-
ing spirometry, lung volumes and diffusion capacity
measurements, and a CAT questionnaire during an
exacerbation-free period were enrolled at Kyoto University
Hospital from April 2011 to April 2014. Lung function
was measured with a Chestac-65 V (Chest MI Corp.,
Tokyo, Japan), and chest CT scans were performed with
an Aquilion 64 scanner (Toshiba; Tokyo, Japan). Calibra-
tion of the CT scanner was routinely performed with air
and water phantoms, and the scanning conditions were as
follows: 0.5-mm collimation, 500-millisecond scan time,
120 peak kilovoltage, and auto-exposure control. Recon-
struction was performed with a high spatial frequency
algorithm (FC56) as previously reported [27].
CT analysis
Airway volume percent (AWV%)
To evaluate the volume of the airways visible on CT im-
ages (Additional file 1: Figure S1A), the entire airway
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tree was automatically segmented without any manual
editing using a SYNAPSE VINCENT volume analyser
Ver5.3 (FUJIFILM Medical, Tokyo, Japan). The seg-
mented airway trees were exported as DICOM files and
further segmented into portions of the right upper lobe
(RUL), right middle-lower lobe (RMLL), and the
remaining lobes with ITK-SNAP software (Additional
file 1: Figure S1B) [29] . The airway tree in the left lung
was not used because segmentation of this area could be
affected by cardiac motion artefacts. The volumes of the
RUL and RMLL were added to obtain the total airway
volume in the right lung (AWV). Right lung volume
(rLV) was also measured, and the airway volume percent
(AWV%) was calculated with the following formula:
AWV% = 100 * AWV / rLV using custom software. Be-
cause the luminal size of the central airways was affected
by the natural size of the lungs, the predicted total lung
capacity (pTLC) was calculated [30] for adjustment of
the AWV and right lung volume.
Total airway count (TAC)
Following the segmentation of the airway trees in the
RUL and RMLL, these segmented trees were skeleton-
ized to obtain their centre lines using custom software.
Each branch of the centre line between branching points
was labelled. Based on this labelling, the airway trees in
the RUL and RMLL were separated into branches, and
all the branched trees were labelled (Additional file 1:
Figure S1C). Corrections of labels were performed
manually when necessary.
Luminal area (Ai) and wall area percent (WA%)
Using the custom software, the lumen and wall of the
right apical and lower posterior segmental and
sub-segmental airways (RB1 and RB10 paths) were seg-
mented with the full-width half-maximum principle as
reported previously [3, 31]. The lumen area (Ai) and wall
area (WA) were measured, and then, the wall area per-
cent (WA%) was calculated using the following formula:
100*WA / (sum of Ai and WA). The average Ai and
WA% from RB1 and RB10 were used for the present
analyses.
Low attenuation volume percent (LAV%)
Using the SYNAPSE VINCENT volume analyser, lung
volume (CT-TLV) and the percentage ratio of voxels <
− 950 HU to the entire lung voxels, namely, the low at-
tenuation volume percent (LAV%), for both lungs and
the right lung alone were measured [8, 16, 27, 32–34].
Statistics
The data are expressed as the mean ± standard devi-
ation (SD). Pearson correlation analysis was used to
evaluate associations among CT measures and
pulmonary function. Multivariate linear regression
analysis including CT indices, age, body mass index
(BMI), and smoking pack-years as independent vari-
ables and each pulmonary function value as
dependent variables was performed. Statistical analysis
was performed with R [35]. A p-value less than 0.05
was considered statistically significant.
Results
The basic data of study subjects are summarized in
Table 1. Figure 1 shows representative 3D renderings of
the airway tree and the right lung in COPD subjects
with mild and severe airflow obstruction (cases A and B,
%FEV1 = 81 and 31%, respectively). Although there was
no difference in height (both 167 cm), the AWV was
smaller (9 vs 18 ml) and right lung volume was larger
(2998 vs 2519 ml) in case B than Case A, which made a
substantial difference in the AWV% between the two
cases.
Data are expressed as the mean ± SD. BMI body mass
index, FEV1 forced expiratory volume in 1 s, FVC forced
vital capacity, RV/TLC residual volume / total lung cap-
acity, DLCO diffusion capacity, CAT COPD Assessment
Test, LAV% low attenuation volume percent, WA% wall
area percent, TAC total airway count.
Figure 2 shows that the AWV/pTLC decreased (A),
rLV/pTLC increased (B) (both p < 0.001 by ANOVA),
and the AWV% decreased as the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) spiromet-
ric grade increased (C)(p < 0.001). The AWV% was
also lower in symptomatic (CAT score≧10) subjects
than non-symptomatic subjects (0.50 ± 0.12% and 0.55
± 0.15%, respectively, p = 0.036, Additional file 1:
Figure S2).
Table 1 Patient demographics (n = 147)
Age 71 ± 9
Sex All male
BMI 22 ± 3
Smoking pack-years 63 ± 35
FEV1 (% predicted) 61 ± 20
FEV1/FVC (%) 51 ± 13
RV/TLC (%) 42 ± 7
TLC (% predicted) 96 ± 13
DLCO (% predicted) 53 ± 14
CAT score ≧10 [n (%)] 81 (55%)
LAV% 29 ± 9
WA% (segmental airways) 58 ± 5
WA% (sub-segmental airways) 64 ± 4
TAC (right lung) 212 ± 51
Tanabe et al. Respiratory Research           (2019) 20:77 Page 3 of 8
Ai luminal area of subsegmental airways, pTLC predicted
TLC, rLV right lung volume, AWV airway volume, AWV%
airway volume percent, LAV% low attenuation volume per-
cent, FEV1 forced expiratory volume in 1 s, RV/TLC residual
volume / total lung capacity, DLCO diffusion capacity.
a and b
indicate p < 0.05 and p < 0.005, respectively
The Pearson correlation tests (Table 2 and Fig. 3)
showed that Ai, Ai/(pTLC)2/3, Ai/(rLV)2/3, rLV, rLV/
pTLC, AWV, AWV/pTLC, and AWV% as well as LAV%
were all correlated with FEV1, %FEV1, and RV/TLC.
Based on the correlation coefficients, the extent of the
correlations in AWV% was higher than in the other
measures of the airway and lung sizes, and similar to
that in LAV%. Moreover, Table 2 and Additional file 1:
Figure S3 show that LAV%, but not AWV%, was associ-
ated with %DLCO and DLCO/VA while both the indexes
were correlated with %TLC. Additional file 1: Figure S4
shows associations of AWV% with TAC, WA%, and
LAV%.
In multivariate analyses (Table 3), AWV% was signifi-
cantly associated with %FEV1 and RV/TLC independent
of LAV%, WA%, and TAC. Additional file 1: Table S1
shows that the multivariate model including both
AWV% and LAV% as independent variables accounted
for more variations of %FEV1 and RV/TLC (R
2 = 0.47
and 0.38, respectively) compared to the models including
either AWV% (R2 = 0.34 and 0.34, respectively) or LAV%
(R2 = 0.21 and 0.22, respectively).
FEV1 forced expiratory volume in 1 s, RV/TLC residual
volume / total lung capacity, LAV% low attenuation volume
percent, WA% wall area percent, TAC total airway count,
and AWV% airway volume percent. βa indicates standardized
β. b adjusted by age, BMI, pack-years, and CT-measured total
lung volume. VIF indicates variance inflation factor
Fig. 1 Representative 3D renderings of airway tree and right lung in 2 COPD cases. A percentage ratio of airway tree volume in the right upper
and middle-lower lobes (AWV, highlighted by yellow colour) to the right lung volume (rLV, brown colour), namely, the airway volume percent
(AWV%), was compared between COPD subjects with mild airflow obstruction (Case A, %FEV1 = 81%, height = 167 cm) and with severe airflow
obstruction (Case B, %FEV1 = 32%, height = 167 cm). Compared to Case A (AWV = 18ml, rLV = 2519 ml), Case B showed smaller airway tree volume
and larger lung volume (AWV = 9ml, rLV = 2998 ml), which resulted in substantially lower AWV%
Fig. 2 Airway and lung measures and severity of COPD (A and B) The airway wall volume (AWV) and right lung volume (rLV) are adjusted by the predicted
total lung capacity (pTLC). (C) The airway wall volume percent (AWV%) was the percentage ratio of the AWV to right lung volume. Statistical analysis with
ANOVA showed significant differences in AWV/pTLC (p=0.00001), rLV/pTLC (p=0.00001), and AWV% (P=0.000001) among different GOLD spirometric grade
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Discussion
This is the first study to assess the interaction of
three-dimensionally measured airway tree and lung
volumes on lung function and symptoms in COPD. Al-
though many CT studies have shown that small lumen
area of the airways and large lung volume are major fea-
tures of COPD and physiological studies have empha-
sized the importance of the relationship between airway
and lung size in terms of structure-function, little atten-
tion has been paid to airway to lung volume ratio in
COPD. Therefore, the present study is important as it
established the AWV% as a novel CT biomarker in
COPD by showing that a reduction of AWV% is signifi-
cantly associated with lower FEV1 and higher RV/TLC
independent of previously reported CT indices such as
Table 2 Pearson correlation coefficients between airway and
lung size indices, emphysema severity, and physiological
measurements
FEV1 (L) %FEV1 (%) RV/TLC (%) %DLCO (%)
Lumen area
Ai (mm2) 0.27b 0.24b −0.24b − 0.05
Ai / (pTLC)2/3 (%) 0.16a 0.18a −0.19a −0.09
Ai / (rLV)2/3 (%) 0.31b 0.32b −0.33b 0.01
Lung volume
rLV (ml) −0.14 −0.21a 0.22a −0.12
rLV / pTLC (%) −0.37b −0.35b 0.33b −0.21a
Airway tree volume
AWV (ml) 0.41b 0.43b −0.35b 0.00
AWV / pTLC (%) 0.27b 0.36b −0.29b −0.06
AWV% (%) 0.48b 0.56b −0.47b 0.07
Emphysema
LAV% −0.48b −0.48b 0.43b −0.62b
Fig. 3 Associations of airway size, lung volume, and airway to lung volume ratio with airflow obstruction. a Percentage ratio of lumen area of
subsegmental airways (Ai) to cubic root squared right lung volume (rLV), b percentage ratio of rLV to predicted total lung capacity (pTLC), c
percentage ratio of airway volume (AWV) to pTLC, and (d) airway volume percent (AWV%) were correlated with percentage of predicted forced
expiratory volume in 1 s (%FEV1). r value indicates the Pearson correlation coefficient. ** indicates p < 0.005
Table 3 Multivariate linear regression analysis to explore the
associations between CT indices and pulmonary function
Model 1 (%FEV1)
b βa VIF p value
LAV% -0.50 2.3 < 0.00001
WA% -0.26 1.6 0.73
TAC 0.21 3.2 0.048
AWV% 0.35 3.6 0.003
Model 2 (RV/TLC)b βa VIF p value
LAV% 0.24 2.3 0.01
WA% -0.17 1.6 0.98
TAC -0.17 3.2 0.14
AWV% -0.28 3.6 0.02
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WA%, LAV%, and TAC. This suggests that a dispropor-
tionally small airway tree for a relatively large lung can
be a major determinant of airflow obstruction and gas
trapping.
The present finding that AWV% is more closely corre-
lated with %FEV1 and RV/TLC than simple measure-
ment of lumen area, airway tree volume, and lung
volume, as well as the ratio of lumen area to the cubic
root squared right lung volume (Table 2), indicates the
advantage of this new CT index. These results also con-
firm the concept that not only each structural change of
airway and lung but also the interaction between these
factors determines lung function. Because the visibility
of airways on CT varies among individuals, it can be
challenging to compare the lumen areas of spatially
matched airways [36]. Thus, our findings suggest that
the use of airway tree volume is more reasonable for
assessment of airway size than that of lumen area.
The demographic data showing that %DLCO was 53 ±
14% and LAV% was 29 ± 9% suggest that the majority of
the subjects had emphysema in this study. Parenchymal
destruction of emphysema could increase lung volume
through loss of elastic recoil and induce thoracic gas
compression during forced expiration on spirometry
[37]. Thus, the increased lung volume due to emphy-
sema might have partially accounted for the close associ-
ation between decreased AWV% and FEV1.
In addition, considering that emphysema can be one
of the causes of the airway volume reduction due to loss
of alveolar attachments to the outer wall of the small air-
ways [21, 22], one would hypothesize that lower AWV%
may be closely associated with higher LAV%. However,
the hypothesis is not well supported by the present data
that showed the weak association between AWV% and
LAV% (r = − 0.24) and no association between AWV%
and diffusion capacity. This might be because in addition
to the impaired airway-parenchymal tethering due to
emphysema, the luminal narrowing due to the mucus
occlusion, bronchoconstriction, and wall remodeling
may also contribute to the reduction in the airway vol-
ume measured on CT.
The results of multivariate analysis show that
AWV% was associated with airflow limitation and gas
trapping independent of LAV%, WA%, and TAC. This
finding suggest that in terms of assessment of the
structure-function relationship, measuring the airway
tree to lung volume ratio is complementary to meas-
uring emphysematous change, impaired visibility of
the airways and wall remodelling of the visible central
airways, which are established CT findings in COPD
lungs [14–17, 38].
The univariate and multivariate analysis (Table 2 and
Table 3) show that both AWV% and LAV% had greater
impacts on %FEV1 and RV/TLC than the other CT
indexes. Furthermore, the statistical model including
both AWV% and LAV% accounted for more variation of
%FEV1 (R
2 = 0.47) than the models including either
AWV% (R2 = 0.34) or LAV% (R2 = 0.21). While emphy-
sema is visually and quantitatively evaluated in clinical
setting, the presence and severity of emphysema is not
directly linked to airflow obstruction [39, 40], which is
measured on spirometry for diagnosis of COPD. Thus,
the present findings propose the potential clinical impli-
cation of AWV% by showing that combining AWV% to
LAV% may allow more accurate estimation of airflow
obstruction than emphysema measurement alone. Fur-
thermore, because AWV% reflects both airway dimen-
sion and lung volume, and bronchodilation and lung
deflation are main targets for standard therapy using
long-acting bronchodilators in COPD [41], AWV%
might sensitively detect an effect of bronchodilator ther-
apy. A future research is needed to test this possibility.
Abnormal lung growth has recently been proposed as
a major contributor to COPD development [26]. Studies
have shown that a variability in associations between
airway and lung size due to dysanaptic lung growth in
early life is associated with lung function [24, 25], and
an increase in lung size without change in airway size
due to chronic hypoxia at higher altitude is associated
with poor lung function [9]. These findings raise the
possibility that the present finding that lower AWV% is
correlated with lower FEV1 and higher RV/TLC might
have been affected by abnormal lung growth. Whether
the combined presence of smaller airways and larger
lung is associated with the early onset of COPD should
be examined in a future study.
With respect to clinical symptoms, the present study
showed that the AWV% was significantly lower in sub-
jects with a CAT score ≥ 10 than in those with a CAT
score < 10. We also performed multivariate logistic re-
gression analysis to test whether a decrease in AWV%
was associated with the presence of symptoms after
adjusting %FEV1, age, BMI, smoking status, and
CT-measured total lung volume but could not detect
significant contribution of the AWV% to symptoms
(data not shown). Because clinical symptoms are influ-
enced by multiple factors including not only airway
disease but also emphysema and systemic comorbidities,
such as cardiovascular disease and depression [42], a lar-
ger sample size would be necessary to clarify the rela-
tionship between the decreased AWV% and symptoms.
It might also be useful to apply a specific questionnaire
for respiratory symptoms, such as Cough and Sputum
Assessment Questionnaire (CASA-Q) [43].
Some limitations need to be described. First, because
the lumen size is underestimated in smaller airways due
to the resolution of CT [12, 44] and measurement of the
AWV% is based on the volumes of all visible airways,
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including these smaller airways, the AWV% might be
underestimated compared to the actual ratio of the air-
way volume to the lung volume. However, we think that
the use of AWV% is valid because the influence of this
underestimation should be equally applied in all CT
scans. Moreover, the fact that all the CT scans were
obtained with one CT scanner under one condition in-
creases the validity of the results. Second, the present
study did not use both lungs for measurement of the
AWV% because cardiac motion artefacts could increase
the measurement error for airway volume in the left
lung. Finally, because all the included patients were
male, and since the size of airways and extent of airway
remodelling differ between males and females [45, 46],
whether the present findings are applicable to female pa-
tients is unclear.
Conclusions
This study established a novel CT marker to evaluate
airway tree to lung volume ratio, AWV%, and showed
that a disproportionately small airway tree volume for a
given lung volume is associated with worsening of air-
flow obstruction and gas trapping. This index is a prom-
ising CT biomarker that is easily measured and allows
for improved understanding of the interaction between
airway disease and lung hyperinflation on lung function
and clinical outcomes in COPD.
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segmentations of airway trees and all branches in the right lung. Figure
S2 The airway volume percent in symptomatic and non-symptomatic
subjects. Figure S3 Associations of the airway volume percent and low
attenuation volume percent with physiological measurements. Figure S4
Associations of the airway volume percent with currently established CT
indexes. Table S1 Multivariate regression models regarding pulmonary
function. (PDF 514 kb)
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